Comparative quality control study of different brands of telmisartan tablets marketed in Andhra Pradesh, India by in-vitro testing
Year: 2025
Type: article
Abstract: InformationTelmisartan is indicated for treating patients with high blood pressure (Hypertension).This study attempted to investigate the In-vitro quality control testing of six prominent pharmaceutical brands of telmisartan tablets marketed in Andhra Pradesh, India.Six different brands of tablets used in the study, named brand A (Telismart 40 mg), brand B (Telmisafe TM-40 mg), brand C (Teltan-40 mg), brand D (Telkonol-40 mg), brand E (telmiwock-40 mg), and brand F (Telmikind-40), were evaluated for weight variation, content uniformity, thickness, disintegration, hardness, friability, and assay.The study utilised standardised testing methods to ensure consistency and reliability across all assessments.The results revealed that all the brands of telmisartan tablets complied with the official specifications for hardness, friability, disintegration, and assay.All the selected brands of telmisartan tablets demonstrated robust mechanical strength, minimal friability, and prompt disintegration of active pharmaceutical ingredients.
Authors: Giddaluri Ramya Sri, Pinni Venkata Navya, Dadhuva Anitha, Madda Nazim Hussain, Chanda Sujith Kumar, Puttagunta Srinivasa Babu, Pusuluri Siva Krishna, Munnangi Mukkanti Eswarudu
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4409598250